Gut Microbiota Characterization in Patients with Asymptomatic Hyperuricemia: probiotics increased
Asymptomatic hyperuricemia (AH) is an early stage of gout. Emerging evidence shows that the intestinal microbiota is related to gout. However, the relationship between AH and the intestinal microbiota is poorly understood. Therefore, the aim of the current study was to explore the possible correlati...
Saved in:
Published in | Bioengineered Vol. 12; no. 1; pp. 7263 - 7275 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Taylor & Francis
01.01.2021
|
Subjects | |
Online Access | Get full text |
ISSN | 2165-5979 2165-5987 2165-5987 |
DOI | 10.1080/21655979.2021.1976897 |
Cover
Abstract | Asymptomatic hyperuricemia (AH) is an early stage of gout. Emerging evidence shows that the intestinal microbiota is related to gout. However, the relationship between AH and the intestinal microbiota is poorly understood. Therefore, the aim of the current study was to explore the possible correlation between AH and intestinal flora. We compared the intestinal microbial communities of AH (45 cases) and healthy subjects (45 cases) by 16S rRNA gene sequencing and clustering analysis on the incorporated population. Intestinal-type clustering can be divided into two groups, and significant differences in the proportion of AH are found among different bowel types. Alpha diversity indices were higher in the AH group than in the control group, and beta diversity indices also showed significant differences. A total of 19 genera were found different between the AH group and the control group. Compared with the control group, some probiotics are increased in the AH population. Two groups were ranked by importance of bacteria. We found the different bacteria partially coincided with the important bacteria, and the joint diagnosis level of the important bacteria was good. Conclusion: There were significant differences in the composition of intestinal biota between AH patients and healthy subjects. Some probiotics increased in AH. |
---|---|
AbstractList | Asymptomatic hyperuricemia (AH) is an early stage of gout. Emerging evidence shows that the intestinal microbiota is related to gout. However, the relationship between AH and the intestinal microbiota is poorly understood. Therefore, the aim of the current study was to explore the possible correlation between AH and intestinal flora. We compared the intestinal microbial communities of AH (45 cases) and healthy subjects (45 cases) by 16S rRNA gene sequencing and clustering analysis on the incorporated population. Intestinal-type clustering can be divided into two groups, and significant differences in the proportion of AH are found among different bowel types. Alpha diversity indices were higher in the AH group than in the control group, and beta diversity indices also showed significant differences. A total of 19 genera were found different between the AH group and the control group. Compared with the control group, some probiotics are increased in the AH population. Two groups were ranked by importance of bacteria. We found the different bacteria partially coincided with the important bacteria, and the joint diagnosis level of the important bacteria was good. Conclusion: There were significant differences in the composition of intestinal biota between AH patients and healthy subjects. Some probiotics increased in AH.Asymptomatic hyperuricemia (AH) is an early stage of gout. Emerging evidence shows that the intestinal microbiota is related to gout. However, the relationship between AH and the intestinal microbiota is poorly understood. Therefore, the aim of the current study was to explore the possible correlation between AH and intestinal flora. We compared the intestinal microbial communities of AH (45 cases) and healthy subjects (45 cases) by 16S rRNA gene sequencing and clustering analysis on the incorporated population. Intestinal-type clustering can be divided into two groups, and significant differences in the proportion of AH are found among different bowel types. Alpha diversity indices were higher in the AH group than in the control group, and beta diversity indices also showed significant differences. A total of 19 genera were found different between the AH group and the control group. Compared with the control group, some probiotics are increased in the AH population. Two groups were ranked by importance of bacteria. We found the different bacteria partially coincided with the important bacteria, and the joint diagnosis level of the important bacteria was good. Conclusion: There were significant differences in the composition of intestinal biota between AH patients and healthy subjects. Some probiotics increased in AH. Asymptomatic hyperuricemia (AH) is an early stage of gout. Emerging evidence shows that the intestinal microbiota is related to gout. However, the relationship between AH and the intestinal microbiota is poorly understood. Therefore, the aim of the current study was to explore the possible correlation between AH and intestinal flora. We compared the intestinal microbial communities of AH (45 cases) and healthy subjects (45 cases) by 16S rRNA gene sequencing and clustering analysis on the incorporated population. Intestinal-type clustering can be divided into two groups, and significant differences in the proportion of AH are found among different bowel types. Alpha diversity indices were higher in the AH group than in the control group, and beta diversity indices also showed significant differences. A total of 19 genera were found different between the AH group and the control group. Compared with the control group, some probiotics are increased in the AH population. Two groups were ranked by importance of bacteria. We found the different bacteria partially coincided with the important bacteria, and the joint diagnosis level of the important bacteria was good. Conclusion: There were significant differences in the composition of intestinal biota between AH patients and healthy subjects. Some probiotics increased in AH. |
Author | Zheng, Ying-Ying Xiu, Wen-Juan Wu, Chen-Xin Hou, Xian-Geng Liu, Jing-Kun Yang, Hai-Tao Wu, Ting-Ting Xie, Xiang Yang, Yi |
Author_xml | – sequence: 1 givenname: Hai-Tao surname: Yang fullname: Yang, Hai-Tao organization: First Affiliated Hospital of Xinjiang Medical University – sequence: 2 givenname: Wen-Juan surname: Xiu fullname: Xiu, Wen-Juan organization: First Affiliated Hospital of Xinjiang Medical University – sequence: 3 givenname: Jing-Kun surname: Liu fullname: Liu, Jing-Kun organization: First Affiliated Hospital of Xinjiang Medical University – sequence: 4 givenname: Yi surname: Yang fullname: Yang, Yi organization: First Affiliated Hospital of Xinjiang Medical University – sequence: 5 givenname: Xian-Geng surname: Hou fullname: Hou, Xian-Geng organization: First Affiliated Hospital of Xinjiang Medical University – sequence: 6 givenname: Ying-Ying surname: Zheng fullname: Zheng, Ying-Ying organization: First Affiliated Hospital of Zhengzhou University, Key Laboratory of Cardiac Injury and Repair of Henan Province – sequence: 7 givenname: Ting-Ting surname: Wu fullname: Wu, Ting-Ting organization: First Affiliated Hospital of Xinjiang Medical University – sequence: 8 givenname: Chen-Xin surname: Wu fullname: Wu, Chen-Xin organization: First Affiliated Hospital of Xinjiang Medical University – sequence: 9 givenname: Xiang surname: Xie fullname: Xie, Xiang email: xiangxie999@sina.com organization: First Affiliated Hospital of Xinjiang Medical University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34590550$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUU1v1DAQtVARLaU_AZQjl13s-CMOSKjVClqkIjj0bs06E9YosYPtUC2_Hi-7WwEHOFgzmpn3nvXeU3Lig0dCnjO6ZFTTVzVTUrZNu6xpzZasbZRum0fkbDdfyFY3Jw99056Si5S-UkoZ5UI2-gk5LbWlUtIzAtdzrj46G8PahQzVagMRbMbofkB2wVfOV59Lhz6n6t7lTXWVtuOUw1iGtrrZThjn6CyODl5X057G2VRwNiIk7J6Rxz0MCS8O9ZzcvX93t7pZ3H66_rC6ul1YoXRe9MC17QRowRRvqGx7hLVCoQBVp2TZ1tiupaqVkJpCZzlHhVILIcpDfk7e7mmneT1iZ8uHIwxmim6EuDUBnPlz493GfAnfjdZUKS4LwcsDQQzfZkzZjC5ZHAbwGOZk6mIdk0xqXk5f_K71IHK0tRy82R8UX1OK2Bvr8i8_i7QbDKNml6M55mh2OZpDjgUt_0IfBf6Hu9zjnO9DHOE-xKEzGbZDiH0Eb10y_N8UPwER5LZ- |
CitedBy_id | crossref_primary_10_2147_DMSO_S429068 crossref_primary_10_3390_microorganisms12040637 crossref_primary_10_3389_fcimb_2022_1051682 crossref_primary_10_1016_j_phymed_2025_156402 crossref_primary_10_1080_21655979_2022_2049959 crossref_primary_10_1080_0886022X_2024_2387429 crossref_primary_10_1016_j_jff_2023_105903 crossref_primary_10_4251_wjgo_v16_i8_3600 crossref_primary_10_1039_D4FO00118D crossref_primary_10_3389_fmicb_2023_1211831 crossref_primary_10_4236_jbm_2022_1011010 crossref_primary_10_3390_gucdd3010001 crossref_primary_10_1016_j_fbio_2023_102912 crossref_primary_10_3389_fcimb_2022_935723 crossref_primary_10_1038_s41598_024_60427_6 crossref_primary_10_7717_peerj_14554 crossref_primary_10_1016_j_heliyon_2023_e20328 crossref_primary_10_1007_s10067_022_06392_9 crossref_primary_10_1080_10408398_2025_2475238 crossref_primary_10_1016_j_ijbiomac_2024_135666 crossref_primary_10_1080_21655979_2021_2019174 crossref_primary_10_3389_fcimb_2024_1341953 crossref_primary_10_1016_j_foodchem_2024_139444 crossref_primary_10_3389_fmed_2023_1163778 crossref_primary_10_3389_frmbi_2024_1384703 crossref_primary_10_1080_21655979_2021_2009752 crossref_primary_10_3389_fnut_2023_1094483 crossref_primary_10_1016_j_jep_2023_116805 |
Cites_doi | 10.1080/19490976.2020.1748258 10.3389/fmicb.2021.631140 10.1186/s10020-021-00311-5 10.1136/annrheumdis-2021-220439 10.1016/j.numecd.2021.01.003 10.1007/s00394-020-02414-x 10.4082/kjfm.2013.34.4.250 10.1002/art.41614 10.1186/s12866-021-02125-1 10.1186/s40168-019-0683-9 10.1016/j.biopha.2020.110719 10.1038/nature09944 10.1136/bcr-2019-230432 10.3390/nu13031008 10.1007/s40618-021-01513-8 10.1186/s12889-021-10858-x 10.1161/JAHA.120.020180 10.1161/CIRCULATIONAHA.118.033714 10.3390/nu12123835 10.1093/ajcn/nqaa350 10.3390/biomedicines8120598 10.1038/srep20602 10.1136/annrheumdis-2019-215933 10.3390/nu13072125 10.1111/1751-7915.13769 10.1080/21655979.2021.1933840 10.3389/fphys.2020.524236 10.1371/journal.pone.0230895 10.1016/j.apsb.2019.10.007 |
ContentType | Journal Article |
Copyright | 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 The Author(s) |
Copyright_xml | – notice: 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 – notice: 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 The Author(s) |
DBID | 0YH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1080/21655979.2021.1976897 |
DatabaseName | Taylor & Francis Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 0YH name: Taylor & Francis Open Access url: https://www.tandfonline.com sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Engineering |
DocumentTitleAlternate | H.-T. YANG ET AL |
EISSN | 2165-5987 |
EndPage | 7275 |
ExternalDocumentID | PMC8806635 34590550 10_1080_21655979_2021_1976897 1976897 |
Genre | Research Article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: National Natural Science Foundation of China grantid: 81770235 |
GroupedDBID | 0YH 4.4 53G ABCCY ABPEM ACGFS ADBBV ADCVX AENEX AIJEM ALMA_UNASSIGNED_HOLDINGS AOIJS BCNDV DGEBU EBS EMOBN GTTXZ H13 IPNFZ M4Z OK1 RIG RPM SV3 TDBHL TFL TFW AAYXX CITATION EJD HYE OVD TEORI TTHFI CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c468t-fa38cd4a841637059feab6e46ae6d65a382e9b56264580adc33e6e58444844e3 |
IEDL.DBID | 0YH |
ISSN | 2165-5979 2165-5987 |
IngestDate | Thu Aug 21 14:11:26 EDT 2025 Fri Jul 11 05:21:23 EDT 2025 Thu Apr 03 06:58:46 EDT 2025 Thu Jul 10 08:13:31 EDT 2025 Thu Apr 24 23:07:56 EDT 2025 Thu Jul 03 04:11:19 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Asymptomatic hyperuricemia diagnostic model 16s rRNA gene gut microbiota probiotics |
Language | English |
License | open-access: http://creativecommons.org/licenses/by/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c468t-fa38cd4a841637059feab6e46ae6d65a382e9b56264580adc33e6e58444844e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Hai-Tao Yang and Wen-Juan Xiu contributed equally to this article. |
OpenAccessLink | https://www.tandfonline.com/doi/abs/10.1080/21655979.2021.1976897 |
PMID | 34590550 |
PQID | 2578151583 |
PQPubID | 23479 |
PageCount | 13 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8806635 informaworld_taylorfrancis_310_1080_21655979_2021_1976897 proquest_miscellaneous_2578151583 crossref_citationtrail_10_1080_21655979_2021_1976897 crossref_primary_10_1080_21655979_2021_1976897 pubmed_primary_34590550 |
PublicationCentury | 2000 |
PublicationDate | 2021-01-01 |
PublicationDateYYYYMMDD | 2021-01-01 |
PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Bioengineered |
PublicationTitleAlternate | Bioengineered |
PublicationYear | 2021 |
Publisher | Taylor & Francis |
Publisher_xml | – name: Taylor & Francis |
References | e_1_3_2_27_1 e_1_3_2_28_1 e_1_3_2_29_1 e_1_3_2_20_1 e_1_3_2_21_1 e_1_3_2_22_1 e_1_3_2_23_1 e_1_3_2_24_1 e_1_3_2_25_1 e_1_3_2_26_1 Wang L (e_1_3_2_31_1) 2017; 37 e_1_3_2_16_1 e_1_3_2_9_1 e_1_3_2_17_1 e_1_3_2_8_1 e_1_3_2_18_1 e_1_3_2_7_1 e_1_3_2_19_1 e_1_3_2_2_1 e_1_3_2_30_1 e_1_3_2_10_1 e_1_3_2_11_1 e_1_3_2_32_1 e_1_3_2_6_1 e_1_3_2_12_1 e_1_3_2_5_1 e_1_3_2_4_1 e_1_3_2_14_1 e_1_3_2_3_1 e_1_3_2_15_1 Li P (e_1_3_2_13_1) 2018; 2018 |
References_xml | – ident: e_1_3_2_19_1 doi: 10.1080/19490976.2020.1748258 – ident: e_1_3_2_27_1 doi: 10.3389/fmicb.2021.631140 – volume: 37 start-page: 678 issue: 5 year: 2017 ident: e_1_3_2_31_1 article-title: [Effects of Clostridium butyricum on serum uric acid and inflammatory mediators in rats with hyperuricemia] publication-title: Nan Fang Yi Ke Da Xue Xue Bao – ident: e_1_3_2_25_1 doi: 10.1186/s10020-021-00311-5 – ident: e_1_3_2_2_1 doi: 10.1136/annrheumdis-2021-220439 – ident: e_1_3_2_4_1 doi: 10.1016/j.numecd.2021.01.003 – ident: e_1_3_2_9_1 doi: 10.1007/s00394-020-02414-x – ident: e_1_3_2_11_1 doi: 10.4082/kjfm.2013.34.4.250 – ident: e_1_3_2_8_1 doi: 10.1002/art.41614 – ident: e_1_3_2_20_1 doi: 10.1186/s12866-021-02125-1 – ident: e_1_3_2_12_1 doi: 10.1186/s40168-019-0683-9 – ident: e_1_3_2_29_1 doi: 10.1016/j.biopha.2020.110719 – ident: e_1_3_2_14_1 doi: 10.1038/nature09944 – ident: e_1_3_2_32_1 doi: 10.1136/bcr-2019-230432 – ident: e_1_3_2_22_1 doi: 10.3390/nu13031008 – ident: e_1_3_2_3_1 doi: 10.1007/s40618-021-01513-8 – ident: e_1_3_2_5_1 doi: 10.1186/s12889-021-10858-x – ident: e_1_3_2_6_1 doi: 10.1161/JAHA.120.020180 – ident: e_1_3_2_18_1 doi: 10.1161/CIRCULATIONAHA.118.033714 – ident: e_1_3_2_7_1 doi: 10.3390/nu12123835 – ident: e_1_3_2_28_1 doi: 10.1093/ajcn/nqaa350 – ident: e_1_3_2_30_1 doi: 10.3390/biomedicines8120598 – ident: e_1_3_2_24_1 doi: 10.1038/srep20602 – volume: 2018 start-page: 3623274 year: 2018 ident: e_1_3_2_13_1 article-title: Zearalenone Changes the Diversity and Composition of Caecum Microbiota in Weaned Rabbit publication-title: Biomed Res Int – ident: e_1_3_2_10_1 doi: 10.1136/annrheumdis-2019-215933 – ident: e_1_3_2_23_1 doi: 10.3390/nu13072125 – ident: e_1_3_2_26_1 doi: 10.1111/1751-7915.13769 – ident: e_1_3_2_16_1 doi: 10.1080/21655979.2021.1933840 – ident: e_1_3_2_17_1 doi: 10.3389/fphys.2020.524236 – ident: e_1_3_2_15_1 doi: 10.1371/journal.pone.0230895 – ident: e_1_3_2_21_1 doi: 10.1016/j.apsb.2019.10.007 |
SSID | ssj0001034578 |
Score | 2.3915315 |
Snippet | Asymptomatic hyperuricemia (AH) is an early stage of gout. Emerging evidence shows that the intestinal microbiota is related to gout. However, the relationship... |
SourceID | pubmedcentral proquest pubmed crossref informaworld |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 7263 |
SubjectTerms | 16s rRNA gene Aged Asymptomatic Diseases Asymptomatic hyperuricemia Bacteria - genetics diagnostic model Feces - microbiology Female Gastrointestinal Microbiome - genetics gut microbiota Humans Hyperuricemia - epidemiology Hyperuricemia - microbiology Male Middle Aged Probiotics Research Paper |
Title | Gut Microbiota Characterization in Patients with Asymptomatic Hyperuricemia: probiotics increased |
URI | https://www.tandfonline.com/doi/abs/10.1080/21655979.2021.1976897 https://www.ncbi.nlm.nih.gov/pubmed/34590550 https://www.proquest.com/docview/2578151583 https://pubmed.ncbi.nlm.nih.gov/PMC8806635 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwELZ4LDAg3pSXjMSaksSO67BVCKiQihiKBFNkp7aIRNOqSQf-PXdxUloEYmCMnLMsn33-7nz-jpDLNA6MFYx5htuhx630PQl-kKes6YDOtRZVbk7_UfSe-cNL1GQTFnVaJfrQ1hFFVLYaN7fSRZMRdxUGAnEwPjMJg3YAB6qMO6tkPQSgiFl9_mvvK8ziMx5V9hilPBRr3vH81tPSCbXEX_oTCv2eTLlwOt1tk60aVtKuWwc7ZMXku2RzgWxwj6j7WUn7mSNeKhW9mVM1u5eYNMvpk2NZLSiGZ2m3-BhNynFF6kp74LBOKwqiUaau6cR1k6UFyCHyLMxwnwzubgc3Pa8usOClXMjSs4ph7SKFV48MVBNbo7QwXCgjhiKC1tDEGhCS4JH01TBlzAgDkAV8Os4NOyBr-Tg3R4RyayLtpzzWCiCJ4hKQnGax9RnMSyhli_BmTpO0Jh_HGhjvSVBzlDaqSFAVSa2KFmnPxSaOfeMvgXhRYUlZhT2sq1GSsD9kLxrtJrDH8OJE5WY8KxI0awj8JGuRQ6ft-XBgecU-uHkt0llaB_MfkL97uSXP3ioebzCdiPeO_zHmE7KBny4mdErWyunMnAFKKvV5tQ8-Af6qCFk |
linkProvider | Taylor & Francis |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB5RONAeKh5t2fKokbiGJmvH6_SGUCFQFnFYJDhZTtZWI0F2RbKH_vvOxMmyi6g49OyMZXnG428mM58BjvIksk5yHljhxoFwKgwUxkGBcXaAOs8y2dTmDK9leisu7-K7hV4YKqukGNp5oojGV9PhpmR0VxL3vR9JAsLUZ9KPjiO8UVUyeAdrscJoAm06vE-f8ywhF3HjkEkqILGukedfMy1dUUsEpq_B0JfVlAvX09kGfGxxJTvxhrAJK7bcgg8LbIPbYM5nNRsWnnmpNux0ztXsWzFZUbIbT7NaMcrPspPqz-O0njSsrizFiPWp4SB6LMwPNvXTFHmFcgQ9Kzv-BKOzn6PTNGhfWAhyIVUdOMPp8SJD_x456iZx1mTSCmmsHMsYR_s2yRAiSRGr0Ixzzq20iFkwqBPC8s-wWk5KuwNMOBtnYS6SzCAmMUIhlMt44kKO-9JXqgei21Odt-zj9AjGg45aktJOFZpUoVtV9OB4Ljb19BtvCSSLCtN1k_dw_pESzd-QPey0q_GQ0Z8TU9rJrNLk1wj5Kd6DL17b8-WgeSUhxnk9GCzZwfwDIvBeHimL3w2RN_pOAnxf_2PN32A9HQ2v9NXF9a9deE9DPkG0B6v108zuI2Sqs4PmTPwFQnkLxA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwEB2VIiF6QHyzQIuRuKYka8drc6vabrdAqx6KBCfLSWwRiWZXTfbQf8-MnSy7iKoHzs5Ylp89fuOM3wB8KHXmvOQ8ccJXifAqTRTGQYn1boKYF4UMuTln53L2TXz-ng_ZhG2fVkkxtI9CEcFX0-ZeVH7IiPs4ziTxYHpmMs72MzxQlZ7cg_u50oEjpT9mf65ZUi7y4I_JKiGz4R3PbT1tnFAb-qX_YqF_J1OunU7Tx_Cop5XsIK6DJ7DlmqewsyY2-AzsybJjZ3UUXuosO1xJNceXmKxu2EVUWW0ZXc-yg_bmatHNg6grm2HAeh0kiK5q-4ktYjd12aIdMc_WVc_hcnp8eThL-gILSSmk6hJvOdUusvTrkSM02jtbSCekdbKSObaOnS6QIUmRq9RWJedOOqQsGNMJ4fgL2G7mjXsFTHiXF2kpdGGRklihkMkVXPuU47yMlRqBGObUlL34ONXA-GWyXqN0gMIQFKaHYgT7K7NFVN-4y0CvA2a6cO3hY40Sw--wfT-ga3CP0Y8T27j5sjXk1oj4KT6ClxHt1XBweekUw7wRTDbWweoD0u_ebGnqn0HHG10n8b3X_zHmd_Dg4mhqvp6ef3kDD6klXg-9he3ueul2kTB1xV7YEr8Bhz8K7Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gut+Microbiota+Characterization+in+Patients+with+Asymptomatic+Hyperuricemia%3A+probiotics+increased&rft.jtitle=Bioengineered&rft.au=Yang%2C+Hai-Tao&rft.au=Xiu%2C+Wen-Juan&rft.au=Liu%2C+Jing-Kun&rft.au=Yang%2C+Yi&rft.date=2021-01-01&rft.issn=2165-5987&rft.eissn=2165-5987&rft.volume=12&rft.issue=1&rft.spage=7263&rft_id=info:doi/10.1080%2F21655979.2021.1976897&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2165-5979&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2165-5979&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2165-5979&client=summon |